Alfredo Ramirez-Gonzalez

Dr. Alfredo Ramirez-Gonzalez

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CCCésar M. Cerecedo-Zapata
César M. Cerecedo-Zapata
YTYessica Sarai Tapia-Guerrero
Yessica Sarai Tapia-Guerrero
ARAlfredo Ramirez-Gonzalez
Alfredo Ramirez-Gonzalez
ADAranza Meza Dorantes
Aranza Meza Dorantes
KTKarla N. Tercero-Pérez
Karla N. Tercero-Pérez
JMJonathan J. Magaña
Jonathan J. Magaña
Spinocerebellar ataxia type 7 (SCA7) is a rare genetic disease characterized by progressive cerebellar syndrome and macular degeneration. In a previous study, we clinically and genetically characterized a group of Mexican patients, which represented one of the largest cohorts of SCA7 patients worldwide and demonstrated that all patients had a unique genetic origin. Our laboratory developed a program for the diagnosis, medical care, and long-term follow-up of these patients living in Veracruz State, and in this report, we present an update to this research, covering 2013 to 2024. So far, we identified 172 SCA7 carriers, with a few cases outside Veracruz, and our data support that the length of the CAG repeat tract mainly determines disease severity and life expectancy, and accordingly, we define three different phenotypes, early-onset (EO), classical-onset (CO), and late-onset (LO), with EO patients showing the lowest life expectancy. Furthermore, we found that parental transmission of mutant alleles leads to increased CAG repeat instability, compared to maternal ones. Interestingly, a haplotype analysis revealed that patients outside Veracruz may have different genetic origins. In conclusion, longitudinal observations of SCA7 patients provide insight into the natural history of SCA7 and help to design strategies for diagnosis, genetic counseling, physical rehabilitation, and therapeutic alternatives.

28 March 2022 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
ARAlfredo Ramirez-Gonzalez
Alfredo Ramirez-Gonzalez
AFAngelica Castañeda de la Fuente
Angelica Castañeda de la Fuente
VCVladimir Castro-Cervantes
Vladimir Castro-Cervantes
CPCarlos Pineda
Carlos Pineda
HSHugo Sandoval
Hugo Sandoval
Alberto Hidalgo-BravoAlberto Hidalgo-Bravo
Alberto Hidalgo-Bravo

1 April 2025 in JCO Global Oncology
Verified
Journal Article
Closed access
TWTalia Wegman
Talia Wegman
LTLUCIA TAJA-CHAYEB
LUCIA TAJA-CHAYEB
ZZZyanya Lucia Zatarain-Barrón
Zyanya Lucia Zatarain-Barrón
CTCatalina Trejo-Becerril
Catalina Trejo-Becerril
ARAlfredo Ramirez-Gonzalez
Alfredo Ramirez-Gonzalez
ARAlejandro Ruiz-Patiño
Alejandro Ruiz-Patiño
The importance of having region-specific data when planning health interventions has become evident in recent years. Nonetheless, several world regions, including Latin America and the Caribbean (LAC), still face significant challenges. These regions need to develop strategies specifically designed to consider the inherent characteristics of their population composite and sociodemographic characteristics. More than 20% of the global cancer incidence arises in LAC. Yet, treatment, prevention, and follow-up guidelines in the area are frequently based on studies that mainly include patients from North America, Europe, and Asia. As personalized approaches become ubiquitous in medical practice, the amount of information emerging from LAC has risen considerably. In this review, we seek to present a comprehensive summary of the frequency of germline genetic variants in hereditary cancer syndromes in patients from LAC. The data highlight relevant differences in variants associated with LAC patients, including founder and recurrent variants, while showcasing potential features that might be relevant in oncology practices.